Diffusion-weighted imaging in evaluating the response to neoadjuvant breast cancer treatment

Breast Journal

Volumn 17, Issue 6, 2011, Pages 610-619

  Belli, Paolo ^a   Costantini, Melania ^a   Ierardi, Carmine ^a   Bufi, Enida ^a   Amato, Daniele ^a   Mule', Antonino ^a   Nardone, Luigia ^a   Terribile, Daniela ^b   Bonomo, Lorenzo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

apparent diffusion coefficient; breast cancer; magnetic resonance imaging; neoadjuvant treatment; response

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CELL DEATH; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

ADULT; AGED; BREAST NEOPLASMS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY;

EID: 80755153208     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2011.01160.x     Document Type: Article

References (48)

1. Chen JH, Feig B, Agrawal G, et al. MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy. Cancer 2008; 112: 17-26.
2. Johansen R, Jensen LR, Rydland J, et al. Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI. J Magn Reson Imaging 2009; 29: 1300-7.
3. Kim HJ, Im YH, Han BK, et al. Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: relation to response patterns on MRI. Acta Oncol, 2007; 46: 996-1003. (Pubitemid 47537188)
4. Iacconi C, Giannelli M, Marini C, et al. The role of mean diffusivity (MD) as a predictive index of the response to chemotherapy in locally advanced breast cancer: a preliminary study. Eur Radiol 2010; 20: 303-8.
5. Loo CE, Teertstra HJ, Rodenhuis S, et al. Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy: initial results. AJR 2008; 191: 1331-8.
6. Gralow JR, Burstein HJ, Wood W, et al. Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease. J Clin Oncol 2008; 26: 814-9. (Pubitemid 351265335)
7. Segara D, Krop IE, Garber JE, et al. Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy? J Surg Oncol 2007; 96: 474-80. (Pubitemid 350044390)
8. Yankeelova TE, Lepagea M, Chakravarthyf A, et al. Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging, 2007; 25: 1-13.
9. Morse DL, Galons JP, Payne CM, et al. MRI-measured water mobility increases in response to chemotherapy via multiple cell-death mechanisms. NMR Biomed 2007; 20: 602-61.
10. Chang J, Powles TJ, Allred DC, et al. Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer. J Clin Oncol 1999; 17: 3058-63. (Pubitemid 29470633)
11. Rajan R, Poniecka A, Smith TL, et al. Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response. Cancer 2004; 7: 1365-73. (Pubitemid 38366838)
12. Rastogi P, Anderson SJ, Bear HD, et al. Preoperative chemotherapy: updates of national surgical adjuvant breast and bowel project protocols B-18 and B-27. J Clin Oncol 2008; 26: 778-85. (Pubitemid 351264391)
13. Smith IC, Heys SD, Hutcheon AW, et al. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol 2002; 20: 1456-66. (Pubitemid 34260523)
14. Kuerer HM, Newman LA, Smith TL, et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 1999; 17: 460-9. (Pubitemid 29075229)
15. Balu-Maestro C, Chapellier C, Bluese A, et al. Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast Cancer Res Treat 2002; 72: 145-52. (Pubitemid 34407209)
16. Delille J-P, Slanetz PJ, Yeh ED, et al. Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging-pilot study. Radiology 2003; 228: 63-9. (Pubitemid 36736070)
17. Gilles R, Guinebretiere JM, Toussaint C, et al. Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 1994; 191: 633-8. (Pubitemid 24177877)
18. Heywang-Koebrunner SH,. Breasts. In:, Bradley WG, Stark DD, eds. Magnetic Resonance Imaging. St. Louis (Mo)7 Mosby: Mosby Inc., 1999: 1401-28.
19. Londero V, Bazzocchi M, Del Frate C, et al. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 2004; 14: 1371-9. (Pubitemid 39162217)
20. Pickles MD, Gibbs P, Lowry M, Turnbull LW,. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 2006; 24: 843-7. (Pubitemid 44205378)
21. Rieber A, Brambs HJ, Gabelmann A, et al. Breast MRI for monitoring response of primary breast cancer to neoadjuvant chemotherapy. Eur Radiol 2002; 12: 1711-9. (Pubitemid 36940255)
22. Schott AF, Roubidoux MA, Helvie MA, et al. Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy. Breast Cancer Res Treat 2005; 92: 231-8. (Pubitemid 41282819)
23. Partrige SC, Gibbs JE, Lu Y, et al. Accuracy of MRI imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR 2002; 179: 1193-9. (Pubitemid 35204372)
24. Rosen EL, Blackwell KL, Baker JA, et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR 2003; 181: 1275-82. (Pubitemid 37296403)
25. Sharmaa U, Danishada KKA, Seenub V, Jagannathana NR,. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed 2009; 22: 104-13.
26. Sardanelli F, Boetes C, Borisch B, Decker T, federico M, Gilbert FJ,. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 2010; 46: 1296-316.
27. Kauppinen RA,. Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy. NMR Biomed 2002; 15: 6-17. (Pubitemid 34177163)
28. Bortner CD, Cidlowski JA,. A necessary role for cell shrinkage in apoptosis. Biochem Pharmacol 1998; 56: 1549-59. (Pubitemid 28561474)
29. Carano RA, Ross AL, Ross J, et al. Quantification of tumor tissue populations by multispectral analysis. Magn Reson Med 2004; 51: 542-51. (Pubitemid 38298668)
30. Hakumaki JM, Poptani H, Puumalainen AM, et al. Quantitative 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response. Cancer Res 1998; 58: 3791-9. (Pubitemid 28405632)
31. Valonen PK, Lehtimaki KK, Vaisanen TH, et al. Water diffusion in a rat glioma during ganciclovir-thymidine kinase gene therapy-induced programmed cell death in vivo: correlation with cell density. J Magn Reson Imaging 2004; 19: 389-96. (Pubitemid 38437145)
32. Zhao F, Kuroiwa T, Miyasaka N, et al. Ultrastructural and MRI study of the substantia nigra evolving exofocal post-ischemic neuronal death in the rat. Neuropathology 2002; 22: 91-105. (Pubitemid 35252701)
33. Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994; 73: 2680-6. (Pubitemid 24166250)
34. Woodhams R, Matsunaga K, Kan S, et al. ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 2005; 4: 35-42.
35. Marini C, Iacconi C, Giannelli M, Cilotti A, Moretti M, Bartolozzi C,. Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast leison. Eur Radiol 2007; 17: 2646-55.
36. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002; 16: 172-8. (Pubitemid 34810055)
37. Kuroki Y, Nasu K, Kuroki S, et al. Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value. Magn Reson Med Sci 2004; 3: 79-85.
38. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1). EJC 2009; 45: 228-47.
39. Woodhams R, Kakita S, Hata H, et al. Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging-comparison with contrast-enhanced MR Imaging and pathologic findings. Radiology 2010; 254: 357-66.
40. Mandard edal,. Pathologic assessment of tumor regression after preoperative chemotherapy of esophageal carcinoma. Clinicopathologic correlation. Cancer 1994; 73: 2680-6.
41. Hanley JA, McNeil BJ,. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 26-36.
42. Evelhoch JL, Gillies RJ, Karczmar GS, et al. Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia 2000; 2: 152-65. (Pubitemid 30123186)
43. Galons JP, Morse DL, Jennings DR, Gillies RJ,. Diffusion-weighted MRI and response to anti-cancer therapies. Isr J Chem 2003; 4: 91-101. (Pubitemid 38497133)
44. Gillies RJ, Bhujwalla ZM, Evelhoch J, et al. Applications of magnetic resonance in model systems: tumor biology and physiology. Neoplasia 2000; 2: 139-51. (Pubitemid 30123185)
45. Moffat BA, Hall DE, Stojanovska J, et al. Diffusion imaging for evaluation of tumor therapies in preclinical animal models. Magn Reson Mater Phys Biol Med 2004; 17: 249-59. (Pubitemid 40362308)
46. Paran Y, Bendel P, Margalit R, Degani H,. Water diffusion in the different microenvironments of breast cancer. NMR Biomed 2004; 17: 170-80. (Pubitemid 39089244)
47. Pickles MD, Lowry M, Manton DJ, Gibbs P, Turnbull LW,. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 2005; 91: 1-10. (Pubitemid 40684933)
48. Theilmann RJ, Borders R, Trouard TP, et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 2004; 6: 831-7. (Pubitemid 40041502)